Oramed Pharmaceuticals
ORMP
#8931
Rank
NZ$0.16 B
Marketcap
$4.20
Share price
-4.82%
Change (1 day)
10.97%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): NZ$39.85 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of NZ$12.61 Million, an increase over its 2022 earnings that were of -NZ$64.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$39.85 M216.02%
2023 NZ$12.61 M-119.45%
2022 -NZ$64.84 Million39.17%
2021 -NZ$46.59 Million73.93%
2020 -NZ$26.79 Million18.53%
2019 -NZ$22.6 Million-16.62%
2018 -NZ$27.11 Million38.32%
2017 -NZ$19.6 Million12.51%
2016 -NZ$17.42 Million25.01%
2015 -NZ$13.94 Million18.18%
2014 -NZ$11.79 Million39.72%
2013 -NZ$8.44 Million46.4%
2012 -NZ$5.77 Million128.32%
2011 -NZ$2.53 Million-51.47%
2010 -NZ$5.21 Million35.21%
2009 -NZ$3.85 Million
2007 -NZ$6.05 Million607.04%
2006 -NZ$0.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.88 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.58 B 72,308.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
NZ$13.11 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$26.77 M-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-NZ$0.39 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA